Review



antibacterial activity against e coli atcc 10536  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC antibacterial activity against e coli atcc 10536
    Cartoon representation of <t>E.</t> <t>coli</t> 70S ribosome (PDB ID 4v7v), where small (30S) and large (50S) subunits are displayed with ribosomal proteins on the left. The investigated region, including the peptidyl transferase center on 23S rRNA, is indicated on 50S on the right. The native inhibitor Clindamycin (CLY) is shown in sticks. Mg 2+ ions in the crystal structure are depicted as magenta spheres.
    Antibacterial Activity Against E Coli Atcc 10536, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2775 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc 10536/product/ATCC
    Average 99 stars, based on 2775 article reviews
    antibacterial activity against e coli atcc 10536 - by Bioz Stars, 2026-05
    99/100 stars

    Images

    1) Product Images from "A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome"

    Article Title: A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome

    Journal: RSC Advances

    doi: 10.1039/d6ra01785a

    Cartoon representation of E. coli 70S ribosome (PDB ID 4v7v), where small (30S) and large (50S) subunits are displayed with ribosomal proteins on the left. The investigated region, including the peptidyl transferase center on 23S rRNA, is indicated on 50S on the right. The native inhibitor Clindamycin (CLY) is shown in sticks. Mg 2+ ions in the crystal structure are depicted as magenta spheres.
    Figure Legend Snippet: Cartoon representation of E. coli 70S ribosome (PDB ID 4v7v), where small (30S) and large (50S) subunits are displayed with ribosomal proteins on the left. The investigated region, including the peptidyl transferase center on 23S rRNA, is indicated on 50S on the right. The native inhibitor Clindamycin (CLY) is shown in sticks. Mg 2+ ions in the crystal structure are depicted as magenta spheres.

    Techniques Used:

    In vitro inhibition of protein synthesis by Clindamycin (control) and the drug candidates in the E. coli cell-free translation system. Error bars represent standard error of the mean. Any error bars that are not visible are smaller than the data symbols.
    Figure Legend Snippet: In vitro inhibition of protein synthesis by Clindamycin (control) and the drug candidates in the E. coli cell-free translation system. Error bars represent standard error of the mean. Any error bars that are not visible are smaller than the data symbols.

    Techniques Used: In Vitro, Inhibition, Control



    Similar Products

    99
    ATCC antibacterial activity against e coli atcc 10536
    Cartoon representation of <t>E.</t> <t>coli</t> 70S ribosome (PDB ID 4v7v), where small (30S) and large (50S) subunits are displayed with ribosomal proteins on the left. The investigated region, including the peptidyl transferase center on 23S rRNA, is indicated on 50S on the right. The native inhibitor Clindamycin (CLY) is shown in sticks. Mg 2+ ions in the crystal structure are depicted as magenta spheres.
    Antibacterial Activity Against E Coli Atcc 10536, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc 10536/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli atcc 10536 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC antibacterial activity against e coli atcc 25922
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Antibacterial Activity Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli atcc 25922 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC significant antibacterial activity against e coli atcc 25922
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Significant Antibacterial Activity Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/significant antibacterial activity against e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    significant antibacterial activity against e coli atcc 25922 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC antibacterial activity against e coli atcc 25922 lux
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Antibacterial Activity Against E Coli Atcc 25922 Lux, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc 25922 lux/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli atcc 25922 lux - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC antibacterial activity against e coli
    A schematic representation of the innovative multifunctional films developed in this study, featuring tryptophan-containing antimicrobial peptides (AMPs) that collectively confer enhanced structural stability, reduced swelling behavior, heightened response sensitivity, and effective <t>antibacterial</t> properties.
    Antibacterial Activity Against E Coli, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC antibacterial activity against e coli atcc
    A schematic representation of the innovative multifunctional films developed in this study, featuring tryptophan-containing antimicrobial peptides (AMPs) that collectively confer enhanced structural stability, reduced swelling behavior, heightened response sensitivity, and effective <t>antibacterial</t> properties.
    Antibacterial Activity Against E Coli Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli atcc - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    95
    ATCC antibacterial activity against e coli 412 atcc 25922
    A schematic representation of the innovative multifunctional films developed in this study, featuring tryptophan-containing antimicrobial peptides (AMPs) that collectively confer enhanced structural stability, reduced swelling behavior, heightened response sensitivity, and effective <t>antibacterial</t> properties.
    Antibacterial Activity Against E Coli 412 Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli 412 atcc 25922/product/ATCC
    Average 95 stars, based on 1 article reviews
    antibacterial activity against e coli 412 atcc 25922 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    Image Search Results


    Cartoon representation of E. coli 70S ribosome (PDB ID 4v7v), where small (30S) and large (50S) subunits are displayed with ribosomal proteins on the left. The investigated region, including the peptidyl transferase center on 23S rRNA, is indicated on 50S on the right. The native inhibitor Clindamycin (CLY) is shown in sticks. Mg 2+ ions in the crystal structure are depicted as magenta spheres.

    Journal: RSC Advances

    Article Title: A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome

    doi: 10.1039/d6ra01785a

    Figure Lengend Snippet: Cartoon representation of E. coli 70S ribosome (PDB ID 4v7v), where small (30S) and large (50S) subunits are displayed with ribosomal proteins on the left. The investigated region, including the peptidyl transferase center on 23S rRNA, is indicated on 50S on the right. The native inhibitor Clindamycin (CLY) is shown in sticks. Mg 2+ ions in the crystal structure are depicted as magenta spheres.

    Article Snippet: Among these candidates, only Mitoxantrone and Daunorubicin exhibited antibacterial activity against E. coli ATCC 10536 (Table S4–S6).

    Techniques:

    In vitro inhibition of protein synthesis by Clindamycin (control) and the drug candidates in the E. coli cell-free translation system. Error bars represent standard error of the mean. Any error bars that are not visible are smaller than the data symbols.

    Journal: RSC Advances

    Article Title: A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome

    doi: 10.1039/d6ra01785a

    Figure Lengend Snippet: In vitro inhibition of protein synthesis by Clindamycin (control) and the drug candidates in the E. coli cell-free translation system. Error bars represent standard error of the mean. Any error bars that are not visible are smaller than the data symbols.

    Article Snippet: Among these candidates, only Mitoxantrone and Daunorubicin exhibited antibacterial activity against E. coli ATCC 10536 (Table S4–S6).

    Techniques: In Vitro, Inhibition, Control

    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of E. coli , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).

    Journal: eBioMedicine

    Article Title: A next-generation probiotic strain for gut health: Bacteroides cellulosilyticus LYH2 variant with anti-inflammatory and metabolic advantages

    doi: 10.1016/j.ebiom.2026.106232

    Figure Lengend Snippet: Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of E. coli , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).

    Article Snippet: Antibacterial activity against E. coli ATCC 25922, S. aureus ATCC 25923, and S. T yphimurium ATCC 14028 was assessed by co-culturing, with detailed methods provided in the .

    Techniques: Bacteria, Cell Culture, Two Tailed Test, Control, Comparison, Co-Culture Assay, Evaporation

    A schematic representation of the innovative multifunctional films developed in this study, featuring tryptophan-containing antimicrobial peptides (AMPs) that collectively confer enhanced structural stability, reduced swelling behavior, heightened response sensitivity, and effective antibacterial properties.

    Journal: Food Chemistry: X

    Article Title: Improving the functional performance of anthocyanin indicator films through antimicrobial peptides incorporation: Enhanced stability, swelling control, and antibacterial efficacy

    doi: 10.1016/j.fochx.2025.103259

    Figure Lengend Snippet: A schematic representation of the innovative multifunctional films developed in this study, featuring tryptophan-containing antimicrobial peptides (AMPs) that collectively confer enhanced structural stability, reduced swelling behavior, heightened response sensitivity, and effective antibacterial properties.

    Article Snippet: Assessment of the antimicrobial efficacy of AMP–anthocyanin composite films. (A) Antibacterial activity against E. coli (ATCC 25922); (B) Antibacterial activity against S. aureus (ATCC 6538), demonstrating the films' inhibitory potential against both Gram–positive and Gram–negative bacteria.

    Techniques:

    Assessment of the antimicrobial efficacy of AMP–anthocyanin composite films. (A) Antibacterial activity against E. coli (ATCC 25922); (B) Antibacterial activity against S. aureus (ATCC 6538), demonstrating the films' inhibitory potential against both Gram–positive and Gram–negative bacteria. The control film refers to a film prepared under the same conditions as the peptide-containing films, except without the addition of antimicrobial peptides (AMPs). For each experimental condition, three independent biological replicates were performed, and each measurement was repeated in technical triplicate ( n = 3). Statistical significance was indicated as follows: ns (not significant), * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Journal: Food Chemistry: X

    Article Title: Improving the functional performance of anthocyanin indicator films through antimicrobial peptides incorporation: Enhanced stability, swelling control, and antibacterial efficacy

    doi: 10.1016/j.fochx.2025.103259

    Figure Lengend Snippet: Assessment of the antimicrobial efficacy of AMP–anthocyanin composite films. (A) Antibacterial activity against E. coli (ATCC 25922); (B) Antibacterial activity against S. aureus (ATCC 6538), demonstrating the films' inhibitory potential against both Gram–positive and Gram–negative bacteria. The control film refers to a film prepared under the same conditions as the peptide-containing films, except without the addition of antimicrobial peptides (AMPs). For each experimental condition, three independent biological replicates were performed, and each measurement was repeated in technical triplicate ( n = 3). Statistical significance was indicated as follows: ns (not significant), * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Article Snippet: Assessment of the antimicrobial efficacy of AMP–anthocyanin composite films. (A) Antibacterial activity against E. coli (ATCC 25922); (B) Antibacterial activity against S. aureus (ATCC 6538), demonstrating the films' inhibitory potential against both Gram–positive and Gram–negative bacteria.

    Techniques: Activity Assay, Bacteria, Control